Can CT screening give rise to a beneficial stage shift in lung cancer patients? Systematic review and meta-analysis

PLoS ONE

Volumn 11, Issue 10, 2016, Pages

  Wang, Zixing ^a   Hu, Yaoda ^a   Wang, Yuyan ^a   Han, Wei ^a   Wang, Lei ^a   Xue, Fang ^a   Sui, Xin ^b   Song, Wei ^b   Shi, Ruihong ^c   Jiang, Jingmei ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^c NATIONAL INSTITUTES FOR FOOD AND DRUG CONTROL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SCREENING; CANCER STAGING; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; EARLY CANCER; EVIDENCE BASED PRACTICE; HUMAN; INTERMETHOD COMPARISON; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; META ANALYSIS; NON SMALL CELL LUNG CANCER; RANDOMIZED CONTROLLED TRIAL (TOPIC); SQUAMOUS CELL LUNG CARCINOMA; SYSTEMATIC REVIEW; THORAX RADIOGRAPHY; TREND STUDY; ADENOCARCINOMA; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; FACTUAL DATABASE; LUNG NEOPLASMS; PATHOLOGY; SMALL CELL LUNG CARCINOMA; X-RAY COMPUTED TOMOGRAPHY;

ADENOCARCINOMA; DATABASES, FACTUAL; EARLY DETECTION OF CANCER; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; SMALL CELL LUNG CARCINOMA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84991338016     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0164416     Document Type: Article

References (52)

1. International Agency for Research on Cancer. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. Available: http://globocan.iarc.fr/Pages/fact-sheets-cancer.aspx.
2. Manser R, Lethaby A, Irving LB, Stone C, Byrnes G, Abramson MJ, et al. Screening for lung cancer. Cochrane Database Syst Rev. 2013; 6: CD001991. doi:10.1002/14651858.CD001991.pub3 PMID: 23794187
3. Seki N, Eguchi K, Kaneko M, Ohmatsu H, Kakinuma R, Matsui E, et al. The adenocarcinoma-specific stage shift in the Anti-lung Cancer Association project: significance of repeated screening for lung cancer for more than 5 years with low-dose helical computed tomography in a high-risk cohort. Lung Cancer. 2010; 67: 318-324. doi:10.1016/j.lungcan.2009.04.016 PMID: 19481832
4. Diederich S, Thomas M, Semik M, Lenzen H, Roos N, Weber A, et al. Screening for early lung cancer with low-dose spiral computed tomography: results of annual follow-up examinations in asymptomatic smokers. Eur Radiol. 2004; 14: 691-702. doi:10.1007/s00330-003-2200-5 PMID: 14727146
5. Li F, Sone S, Abe H, MacMahon H, Doi K. Low-dose computed tomography screening for lung cancer in a general population: characteristics of cancer in non-smokers versus smokers. Acad Radiol. 2003; 10: 1013-1020. PMID: 13678090
6. Shaham D, Breuer R, Copel L, Agid R, Makori A, Kisselgoff D, et al. Computed tomography screening for lung cancer: applicability of an international protocol in a single-institution environment. Clin Lung Cancer. 2006; 7: 262-267. doi:10.3816/CLC.2006.n.004 PMID: 16512980
7. Nawa T, Nakagawa T, Kusano S, Kawasaki Y, Sugawara Y, Nakata H. Lung cancer screening using low-dose spiral CT: results of baseline and 1-year follow-up studies. Chest. 2002; 122: 15-20. PMID: 12114333
8. Swensen SJ, Jett JR, Hartman TE, Midthun DE, Mandrekar SJ, Hillman SL, et al. CT screening for lung cancer: five-year prospective experience. Radiology. 2005; 235: 259-265. doi:10.1148/radiol.2351041662 PMID: 15695622
9. Chong S, Lee KS, Chung MJ, Kim TS, Kim H, Kwon OJ, et al. Lung cancer screening with low-dose helical CT in Korea: experiences at the Samsung Medical Center. J Korean Med Sci. 2005; 20: 402-408. doi:10.3346/jkms.2005.20.3.402 PMID: 15953860
10. Bastarrika G, García-Velloso MJ, Lozano MD, Montes U, Torre W, Spiteri N, et al. Early lung cancer detection using spiral computed tomography and positron emission tomography. Am J Respir Crit Care Med. 2005; 171: 1378-1383. doi:10.1164/rccm.200411-1479OC PMID: 15790860
11. Veronesi G, Maisonneuve P, Rampinelli C, Bertolotti R, Petrella F, Spaggiari L, et al. Computed tomography screening for lung cancer: results of ten years of annual screening and validation of cosmos prediction model. Lung Cancer. 2013; 82: 426-430. doi:10.1016/j.lungcan.2013.08.026 PMID: 24099665
12. Gohagan JK, Marcus PM, Fagerstrom RM, Pinsky PF, Kramer BS, Prorok PC, et al. Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer. Lung Cancer. 2005; 47:9-15. doi:10.1016/j.lungcan.2004.06.007 PMID: 15603850
13. Infante M, Cavuto S, Lutman FR, Brambilla G, Chiesa G, Ceresoli G, et al. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J RespirCrit Care Med. 2009; 180: 445-453.
14. Wilson DO, Weissfeld JL, Fuhrman CR, Fisher SN, Balogh P, Landreneau RJ, et al. The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan. Am J RespirCrit Care Med. 2008; 178: 956-961.
15. National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365: 395-409. doi:10.1056/NEJMoa1102873 PMID: 21714641
16. Menezes RJ, Roberts HC, Paul NS, McGregor M, Chung TB, Patsios D, et al. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience. Lung Cancer. 2010; 67: 177-183. doi:10.1016/j.lungcan.2009.03.030 PMID: 19427055
17. Liu X, Liang M, Wang Y, Chen K, Chen X, Qin P, et al. The outcome differences of CT screening for lung cancer pre and post following an algorithm in Zhuhai, China. Lung Cancer. 2011; 73: 230-236. doi:10.1016/j.lungcan.2010.11.012 PMID: 21168238
18. Horeweg N, Scholten ET, de Jong PA, van der Aalst CM, Weenink C, Lammers JW, et al. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. Lancet Oncol. 2014; 15: 1342-1350. doi:10.1016/S1470-2045(14)70387-0 PMID: 25282284
19. Lopes Pegna A, Picozzi G, Falaschi F, Carrozzi L, Falchini M, Carozzi FM, et al. Four-year results of low-dose CT screening and nodule management in the ITALUNG trial. J Thorac Oncol. 2013; 8: 866-875. doi:10.1097/JTO.0b013e31828f68d6 PMID: 23612465
20. Saghir Z, Dirksen A, Ashraf H, Bach KS, Brodersen J, Clementsen PF, et al. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax. 2012; 67: 296-301. doi:10.1136/thoraxjnl-2011-200736 PMID: 22286927
21. Pelosi G, Sonzogni A, Veronesi G, De Camilli E, Maisonneuve P, Spaggiari L, et al. Pathologic and molecular features of screening low-dose computed tomography (LDCT)-detected lung cancer: a baseline and 2-year repeat study. Lung Cancer. 2008; 62: 202-214. doi:10.1016/j.lungcan.2008.03.012 PMID: 18450320
22. Pastorino U, Rossi M, Rosato V, Marchianò A, Sverzellati N, Morosi C, et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev. 2012; 21: 308-315. doi:10.1097/CEJ.0b013e328351e1b6 PMID: 22465911
23. Becker N, Motsch E, Gross ML, Eigentopf A, Heussel CP, Dienemann H, et al. Randomized Study on Early Detection of Lung Cancer with MSCT in Germany: Results of the First 3 Years of Follow-up After Randomization. J Thorac Oncol. 2015; 10: 890-896. doi:10.1097/JTO.0000000000000530 PMID: 25783198
24. Tang W, Wu N, Huang Y, Wang J, Zhao S, Xu Z, et al. Results of low-dose computed tomography (LDCT) screening for early lung cancer: prevalence in 4690 asymptomatic participants. ZhonghuaZhong Liu ZaZhi. 2014; 36: 549-554.[in Chinese]
25. Rzyman W, Dziedzic R, Jelitto-Górska M, Biadacz I, Książek J, Siebert J, et al. Results of an open-access lung cancer screening program with low-dose computed tomography: the Gdańsk experience. Pol Arch Med Wewn. 2015; 125: 232-239. PMID: 25764248
26. McKee BJ, Hashim JA, French RJ, McKee AB, Hesketh PJ, Lamb CR, Williamson C, et al. Experience with a CT screening program for individuals at high risk for developing lung cancer. J Am Coll Radiol. 2015; 12: 192-197. doi:10.1016/j.jacr.2014.08.002 PMID: 25176498
27. Mulshine JL, D'Amico TA. Issues with implementing a high-quality lung cancer screening program. CA Cancer J Clin. 2014; 64: 351-363.
28. Jones GS, Baldwin DR. Lung cancer screening and management. Minerva Med. 2015; 106: 339-354. PMID: 26605556
29. Seki N, Eguchi K, Kaneko M, Ohmatsu H, Kakinuma R, Matsui E, et al. The adenocarcinoma-specific stage shift in the Anti-lung Cancer Association project: significance of repeated screening for lung cancer for more than 5 years with low-dose helical computed tomography in a high-risk cohort. Lung Cancer. 2010; 67: 318-324. doi:10.1016/j.lungcan.2009.04.016 PMID: 19481832
30. Bach PB. Is our natural-history model of lung cancer wrong? Lancet Oncol. 2008; 9: 693-697. doi:10.1016/S1470-2045(08)70176-1 PMID: 18598934
31. Hillerdal G. Indolent lung cancers-time for a paradigm shift: a review. J Thorac Oncol. 2008; 3: 208-211. doi:10.1097/JTO.0b013e3181653ce3 PMID: 18317061
32. Patz EF Jr, Pinsky P, Gatsonis C, Sicks JD, Kramer BS, Tammemägi MC, et al. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med. 2014; 174: 269-274. doi:10.1001/jamainternmed.2013.12738 PMID: 24322569
33. Young RP, Hopkins RJ. Mortality Reduction, Overdiagnosis, and the Benefit-to-Harm Ratio of Computed Tomography Screening. Am J Respir Crit Care Med. 2015; 192: 398-399.
34. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011; 155: 529-536. doi:10.7326/0003-4819-155-8-201110180-00009 PMID: 22007046
35. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM. Ann Surg Oncol. 2010; 17: 1471-1474. doi:10.1245/s10434-010-0985-4 PMID: 20180029
36. Travis WD, Brambilla E, Noguchi M, Geisinger K, Beer D, Powell CA, et al. The new IASLC/ATS/ERS international multidisciplinary lung adenocarcinoma classification. J Thorac Oncol. 2011; 6: 244-285. doi:10.1097/JTO.0b013e318206a221 PMID: 21252716
37. Nyaga VN, Arbyn M, Aerts M. Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Health. 2014; 72: 39. doi:10.1186/2049-3258-72-39 PMID: 25810908
38. Humphrey LL, Deffebach M, Pappas M, Baumann C, Artis K, Mitchell JP, et al. Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation. Ann Intern Med. 2013; 159: 411-420. doi:10.7326/0003-4819-159-6-201309170-00690 PMID: 23897166
39. Usman Ali M, Miller J, Peirson L, Fitzpatrick-Lewis D, Kenny M, Sherifali D, et al. Screening for lung cancer: A systematic review and meta-analysis. Prev Med. 2016; 89: 301-314. doi:10.1016/j.ypmed.2016.04.015 PMID: 27130532
40. Nawa T, Nakagawa T, Mizoue T, Endo K. Low-dose computed tomography screening in Japan. J Thorac Imaging. 2015; 30: 108-114. doi:10.1097/RTI.0000000000000138 PMID: 25658475
41. Zhao SJ, Wu N. Early detection of lung cancer: Low-dose computed tomography screening in China. Thorac Cancer. 2015; 6: 385-389. doi:10.1111/1759-7714.12253 PMID: 26273391
42. Henschke CI, Yankelevitz DF, Libby D, Kimmel M. CT screening for lung cancer: the first ten years. Cancer J. 2002;suppl1: : S47-S54.
43. Young RP, Duan F, Chiles C, Hopkins RJ, Gamble GD, Greco EM, et al. Airflow Limitation and Histology Shift in the National Lung Screening Trial. The NLST-ACRIN Cohort Substudy. Am J Respir Crit Care Med. 2015; 192: 1060-1067. doi:10.1164/rccm.201505-0894OC PMID: 26199983
44. Braillon A. Bronchioalveolar lung cancer: screening and overdiagnosis. J Clin Oncol. 2014; 32: 3575.
45. Young RP, Hopkins RJ. Stage shift in computed tomography screening: possible role of indolent cancers, "histology shift," and overdiagnosis. Am J Respir Crit Care Med. 2013; 188: 1034-1035. doi:10.1164/rccm.201305-0832LE PMID: 24127805
46. Veronesi G, Maisonneuve P, Bellomi M, Rampinelli C, Durli I, Bertolotti R, et al. Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study. Ann Intern Med. 2012; 157: 776-784. doi:10.7326/0003-4819-157-11-201212040-00005 PMID: 23208167
47. Wilson DO, Ryan A, Fuhrman C, Schuchert M, Shapiro S, Siegfried JM, et al. Doubling times and CT screen-detected lung cancers in the Pittsburgh Lung Screening Study. Am J Respir Crit Care Med. 2012; 185: 85-89. doi:10.1164/rccm.201107-1223OC PMID: 21997335
48. Vazquez M, Carter D, Brambilla E, Gazdar A, Noguchi M, Travis WD, et al. Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: histopathologic features and their prognostic implications. Lung Cancer. 2009; 64: 148-154. doi:10.1016/j.lungcan.2008.08.009 PMID: 18951650
49. Yousem SA, Beasley MB. Bronchioloalveolar Carcinoma: A Review of Current Concepts and Evolving Issues. Arch Pathol Lab Med. 2007; 131: 1027-1032. doi:10.1043/1543-2165(2007)131[1027:BCAROC]2.0.CO;2 PMID: 17616987
50. Silvestri GA. Screening for lung cancer: it works, but does it really work? Ann Intern Med. 2011; 155: 537-539. doi:10.7326/0003-4819-155-8-201110180-00364 PMID: 21893614
51. Silva M, Galeone C, Sverzellati N, Marchianò A, Calareso G, Sestini S, et al. Screening with Low-Dose Computed Tomography Does Not Improve Survival of Small Cell Lung Cancer. J Thorac Oncol. 2016; 11: 187-193. doi:10.1016/j.jtho.2015.10.014 PMID: 26845115
52. Spiro SG, Hackshaw A, LungSEARCH Collaborative Group. Research in progress-LungSEARCH: a randomised controlled trial of surveillance for the early detection of lung cancer in a high-risk group. Thorax. 2016; 71: 91-93. doi:10.1136/thoraxjnl-2015-207433 PMID: 26138736